This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Yunying Biopharmaceutical Technology Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Biography of Inventor Yonghua Sun
Introduction: Yonghua Sun is a prominent inventor based in Shanghai, China. He is known for his innovative contributions to the field of biopharmaceutical technology. His work focuses on developing advanced therapeutic solutions for cancer treatment.
Latest Patents: Yonghua Sun holds a patent for an oncolytic virus vector and its application. The patent describes a recombinant nucleic acid that includes a first nucleic acid fragment encoding a soluble PD-1 molecule, a second nucleic acid fragment encoding a CD86 molecule, and a third nucleic acid fragment encoding an antibody to a CD3 molecule. This invention has the potential to significantly impact cancer therapy.
Career Highlights: Yonghua Sun is associated with Shanghai Yunying Biopharmaceutical Technology Co., Ltd., where he applies his expertise in biopharmaceutical research and development. His work has contributed to advancements in the treatment of various cancers.
Collaborations: Throughout his career, Yonghua Sun has collaborated with notable professionals in the field, including Ziying Gong and Daoyun Zhang. These collaborations have fostered innovation and enhanced the development of new therapeutic approaches.
Conclusion: Yonghua Sun's contributions to the field of biopharmaceutical technology exemplify his commitment to advancing cancer treatment. His innovative work continues to inspire future research and development in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile